相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Targeting metastatic cancer
Karuna Ganesh et al.
NATURE MEDICINE (2021)
The bone microenvironment invigorates metastatic seeds for further dissemination
Weijie Zhang et al.
CELL (2021)
Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast-Driven Nutritional Support and Immunosuppression
Ralph Francescone et al.
CANCER DISCOVERY (2021)
The ABC subfamily A transporters: Multifaceted players with incipient potentialities in cancer
Michela Pasello et al.
SEMINARS IN CANCER BIOLOGY (2020)
Metastasis-initiating cells induce and exploit a fibroblast niche to fuel malignant colonization of the lungs
Maren Pein et al.
NATURE COMMUNICATIONS (2020)
Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy
Dina Morein et al.
FRONTIERS IN IMMUNOLOGY (2020)
Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
Lia Walcher et al.
FRONTIERS IN IMMUNOLOGY (2020)
Cancer Stem Cell Plasticity - A Deadly Deal
Archana P. Thankamony et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Plasticity of Cancer Stem Cell: Origin and Role in Disease Progression and Therapy Resistance
Plabon Kumar Das et al.
STEM CELL REVIEWS AND REPORTS (2020)
Limiting tumor seeding as a therapeutic approach for metastatic disease
Asurayya Worrede et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Cancer treatment and survivorship statistics, 2019
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Recent Advances Targeting CCR5 for Cancer and Its Role in Immuno-Oncology
Xuanmao Jiao et al.
CANCER RESEARCH (2019)
Are 90% of deaths from cancer caused by metastases?
Hanna Dillekas et al.
CANCER MEDICINE (2019)
Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance
Piyush B. Gupta et al.
CELL STEM CELL (2019)
Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment
Adele Chimento et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization
Ekrem Emrah Er et al.
NATURE CELL BIOLOGY (2018)
Metastatic niche functions and therapeutic opportunities
Toni Celia-Terrassa et al.
NATURE CELL BIOLOGY (2018)
Specificity of RNAi, LNA and CRISPRi as loss-of-function methods in transcriptional analysis
Lovorka Stojic et al.
NUCLEIC ACIDS RESEARCH (2018)
Targeting cancer stem cells in the clinic: Current status and perspectives
Stephanie Annett et al.
PHARMACOLOGY & THERAPEUTICS (2018)
CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells
Santosh Kumar Singh et al.
SCIENTIFIC REPORTS (2018)
Impeding Circulating Tumor Cell Reseeding Decelerates Metastatic Progression and Potentiates Chemotherapy
Chen Qian et al.
MOLECULAR CANCER RESEARCH (2018)
Targeting cancer stem cells and their niche: perspectives for future therapeutic targets and strategies
Yue Zhao et al.
SEMINARS IN CANCER BIOLOGY (2018)
Chemotherapy resistance and stemness in mitotically quiescent human breast cancer cells identified by fluorescent dye retention
Lewis A. Quayle et al.
CLINICAL & EXPERIMENTAL METASTASIS (2018)
Clinical landscape of cancer metastases
Matias Riihimaeki et al.
CANCER MEDICINE (2018)
SALL4 as a transcriptional and epigenetic regulator in normal and leukemic hematopoiesis
Jianchang Yang
BIOMARKER RESEARCH (2018)
Emergent role of the fractalkine axis in dissemination of peritoneal metastasis from epithelial ovarian carcinoma
H. Gurler Main et al.
ONCOGENE (2017)
Cooperation among heterogeneous prostate cancer cells in the bone metastatic niche
K. Shahriari et al.
ONCOGENE (2017)
A conduit to metastasis: circulating tumor cell biology
Douglas S. Micalizzi et al.
GENES & DEVELOPMENT (2017)
Tumor-Initiating Cells: a criTICal review of isolation approaches and new challenges in targeting strategies
Komal Qureshi-Baig et al.
MOLECULAR CANCER (2017)
The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer
Angela M. Krebs et al.
NATURE CELL BIOLOGY (2017)
Cancer stem cells revisited
Eduard Batlle et al.
NATURE MEDICINE (2017)
Clonal cooperativity in heterogenous cancers
Hengbo Zhou et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)
Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
Wenzhe Li et al.
SCIENTIFIC REPORTS (2017)
Advances in cancer stem cell targeting: How to strike the evil at its root
Brigitte M. Puetzer et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Fractalkine/CX3CR1 axis modulated the development of pancreatic ductal adenocarcinoma via JAK/STAT signaling pathway
LiYa Huang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Pluripotency factor Nanog is tumorigenic by deregulating DNA damage response in somatic cells
J. Kim et al.
ONCOGENE (2016)
The role of ATP-binding cassette transporter genes in the progression of prostate cancer
Omer F. Karatas et al.
PROSTATE (2016)
CRISPR Interference Efficiently Induces Specific and Reversible Gene Silencing in Human iPSCs
Mohammad A. Mandegar et al.
CELL STEM CELL (2016)
SALL4, the missing link between stem cells, development and cancer
Hiro Tatetsu et al.
GENE (2016)
Distinctive properties of metastasis-initiating cells
Toni Celia-Terrassa et al.
GENES & DEVELOPMENT (2016)
Novel Small-Molecule CX3CR1 Antagonist Impairs Metastatic Seeding and Colonization of Breast Cancer Cells
Fei Shen et al.
MOLECULAR CANCER RESEARCH (2016)
Metastatic colonization by circulating tumour cells
Joan Massague et al.
NATURE (2016)
Activated tumor cell integrin αvβ3 cooperates with platelets to promote extravasation and metastasis from the blood stream
Martin R. Weber et al.
THROMBOSIS RESEARCH (2016)
CSCdb: a cancer stem cells portal for markers, related genes and functional information
Yi Shen et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2016)
Weekly docetaxel in the treatment of metastatic breast cancer
Sergio Palmeri
Therapeutics and Clinical Risk Management (2016)
The emerging roles of Oct4 in tumor-initiating cells
Ying-Jie Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2015)
Role of chemokine CX3CL1 in progression of multiple myeloma via CX3CR1 in bone microenvironments
Akinori Wada et al.
ONCOLOGY REPORTS (2015)
CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models
Giovanni Luca Gravina et al.
PROSTATE (2015)
Mammosphere Formation Assay from Human Breast Cancer Tissues and Cell Lines
Ylenia Lombardo et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
Cancer stem cell plasticity and tumor hierarchy
Marina Carla Cabrera et al.
WORLD JOURNAL OF STEM CELLS (2015)
Surviving at a Distance: Organ-Specific Metastasis
Anna C. Obenauf et al.
TRENDS IN CANCER (2015)
Targeting tumor-stromal interactions in bone metastasis
Mark Esposito et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Expression of CX3CR1 associates with cellular migration, metastasis, and prognosis in human clear cell renal cell carcinoma
Xin Yao et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Halting metastasis through CXCR4 inhibition
Deborah M. Ramsey et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity
Christine L. Chaffer et al.
CELL (2013)
Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells
Seog-Young Kim et al.
CELLULAR SIGNALLING (2013)
A genetic and developmental pathway from STAT3 to the OCT4-NANOG circuit is essential for maintenance of ICM lineages in vivo
Dang Vinh Do et al.
GENES & DEVELOPMENT (2013)
Molecular regulation of stem cell quiescence
Tom H. Cheung et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
CXC Chemokine Receptor 4 is Essential for Maintenance of Renal Cell Carcinoma-Initiating Cells and Predicts Metastasis
Maximilian Gassenmaier et al.
STEM CELLS (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Glycomechanics of the Metastatic Cascade: Tumor Cell-Endothelial Cell Interactions in the Circulation
Yue Geng et al.
ANNALS OF BIOMEDICAL ENGINEERING (2012)
Fractalkine Receptor CX(3)CR1 Is Expressed in Epithelial Ovarian Carcinoma Cells and Required for Motility and Adhesion to Peritoneal Mesothelial Cells
Mijung Kim et al.
MOLECULAR CANCER RESEARCH (2012)
The Primacy of β1 Integrin Activation in the Metastatic Cascade
Hisashi Kato et al.
PLOS ONE (2012)
JAK2 the future: therapeutic strategies for JAK-dependent malignancies
Lindsay M. LaFave et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Molecular signatures database (MSigDB) 3.0
Arthur Liberzon et al.
BIOINFORMATICS (2011)
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
Piyush B. Gupta et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
Christine L. Chaffer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Perspective on Cancer Cell Metastasis
Christine L. Chaffer et al.
SCIENCE (2011)
The chemokine receptor CX(3)CR1 is directly involved in the arrest of breast cancer cells to the skeleton
Whitney L. Jamieson-Gladney et al.
BREAST CANCER RESEARCH (2011)
THE ROLE OF SALL4 IN EMBRYONIC STEM CELL PLURIPOTENCY
S. Rao et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Transiently Entrapped Circulating Tumor Cells Interact with Neutrophils to Facilitate Lung Metastasis Development
Sung Jin Huh et al.
CANCER RESEARCH (2010)
The chemokine system in cancer biology and therapy
Alberto Mantovani et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Human glioblastoma tumours and neural cancer stem cells express the chemokine CX3CL1 and its receptor CX3CR1
Marco Erreni et al.
EUROPEAN JOURNAL OF CANCER (2010)
A Novel SALL4/OCT4 Transcriptional Feedback Network for Pluripotency of Embryonic Stem Cells
Jianchang Yang et al.
PLOS ONE (2010)
Role of Oct4 in maintaining and regaining stem cell pluripotency
Guilai Shi et al.
STEM CELL RESEARCH & THERAPY (2010)
Human glioma tumors express high levels of the chemokine receptor CX3CR1
Marco Locatelli et al.
EUROPEAN CYTOKINE NETWORK (2010)
Optimal use of taxanes in metastatic breast cancer
Karen M King et al.
Current Oncology (2009)
Roles of Sall4 in the generation of pluripotent stem cells from blastocysts and fibroblasts
Noriko Tsubooka et al.
GENES TO CELLS (2009)
CX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1/fractalkine in the bone marrow: Potential role in prostate cancer bone tropism
Whitney L. Jamieson et al.
CANCER RESEARCH (2008)
Synchronization of the cell cycle using lovastatin
Sonia JavanMoghadam-Kamrani et al.
CELL CYCLE (2008)
Micrometastatic disease in breast cancer: Clinical implications
Michail Igntiadis et al.
EUROPEAN JOURNAL OF CANCER (2008)
Review: Biological relevance of disseminated tumor cells in cancer patients
Sabine Riethdorf et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors
Ittai Ben-Porath et al.
NATURE GENETICS (2008)
Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells
Jianchang Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Fractalkine upregulates intercellular adhesion molecule-1 in endothelial cells through CX3CR1 and the jak-stat5 pathway
Xiao Ping Yang et al.
CIRCULATION RESEARCH (2007)
Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo
Guangyu Gu et al.
CANCER RESEARCH (2007)
Fractalkine stimulates angiogenesis by activating the Raf-1/MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways
Seon-Jin Lee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Drug penetration in solid tumours
Andrew I. Minchinton et al.
NATURE REVIEWS CANCER (2006)
Chemokines, chemokine receptors, and cancer metastasis
Takashi Kakinuma et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity
P Dorr et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Core transcriptional regulatory circuitry in human embryonic stem cells
LA Boyer et al.
CELL (2005)
Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: Pivotal role of the SDF-1-CXCR4 axis
M Kucia et al.
STEM CELLS (2005)
CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells
SA Shulby et al.
CANCER RESEARCH (2004)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4
S Hatse et al.
FEBS LETTERS (2002)
The IARC TP53 database: New Online mutation analysis and recommendations to users
M Olivier et al.
HUMAN MUTATION (2002)